C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology

Objective. To assess relationship of high sensitivity C reactive protein (hsCRP) level in pts with antiphospholipid syndrome (APS) with clinico-laboratory features and cardiovascular pathology. Material and methods. 206 pts were included. 58 from them had primary APS (PAPS), 72 –systemic lupus eryt...

Full description

Saved in:
Bibliographic Details
Main Authors: N V Seredavkina, T M Reshetnyak, E N Alexandrova, A A Novikov, E S Mach, T V Popkova
Format: Article
Language:Russian
Published: IMA PRESS LLC 2009-08-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/1059
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849400023152852992
author N V Seredavkina
T M Reshetnyak
E N Alexandrova
A A Novikov
E S Mach
T V Popkova
author_facet N V Seredavkina
T M Reshetnyak
E N Alexandrova
A A Novikov
E S Mach
T V Popkova
author_sort N V Seredavkina
collection DOAJ
description Objective. To assess relationship of high sensitivity C reactive protein (hsCRP) level in pts with antiphospholipid syndrome (APS) with clinico-laboratory features and cardiovascular pathology. Material and methods. 206 pts were included. 58 from them had primary APS (PAPS), 72 –systemic lupus erythematosus (SLE) with APS and 76 – SLE. 29 from 76 pts of the latter group were positive on anticardiolipin antibodies (ACA) – SLE with antiphospholipid antibodies (APhL) and 47 – low positive or negative on ACA – SLE without APhL. 72 persons without autoimmune diseases were included into control group. CRP (with high sensitivity immuno-nephelometric assay), APhL (with solid phase immuno-enzyme assay), plasma lipids were evaluated, sonography with measurement of intima-media complex (IMC) thickness of common carotid arteries, carotid artery bulbs and internal carotid arteries, electrocardiography (ECG), echocardiography (EchoCG), Holter ECG monitoring were performed. Results. HsCRP serum level in pts was significantly higher than in control: 2,55 [0,71; 7,04] mg/l (varied from 0,15 to 39,85) vs 0,68 [0,26; 1,97] mg/l (varied from 0,1 to 9,61), p<0,001. Most high hsCRP concentration was found in SLE with APS (p=0,02). HsCRP level in pts with PAPS with history of combined or isolated arterial thrombosis was significantly higher than in pts with SLE and APS having the same localization of thrombosis. HsCRP concentration less than 3 mg/l correlated with duration of postthrombotic period in pts with PAPS. HsCRP level also correlated with triglyceride concentration, body mass index, summated coronary risk and magistral arteries IMC thickness. Conclusion. HsCRP elevation in pts with APS was associated with development of combined and arterial thrombosis as well as with traditional risk factors of atherosclerosis.
format Article
id doaj-art-2c8e13d701ee414abe43d404f5dafb98
institution Kabale University
issn 1995-4484
1995-4492
language Russian
publishDate 2009-08-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-2c8e13d701ee414abe43d404f5dafb982025-08-20T03:38:12ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922009-08-01474111910.14412/1995-4484-2009-1145999C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathologyN V SeredavkinaT M ReshetnyakE N AlexandrovaA A NovikovE S MachT V PopkovaObjective. To assess relationship of high sensitivity C reactive protein (hsCRP) level in pts with antiphospholipid syndrome (APS) with clinico-laboratory features and cardiovascular pathology. Material and methods. 206 pts were included. 58 from them had primary APS (PAPS), 72 –systemic lupus erythematosus (SLE) with APS and 76 – SLE. 29 from 76 pts of the latter group were positive on anticardiolipin antibodies (ACA) – SLE with antiphospholipid antibodies (APhL) and 47 – low positive or negative on ACA – SLE without APhL. 72 persons without autoimmune diseases were included into control group. CRP (with high sensitivity immuno-nephelometric assay), APhL (with solid phase immuno-enzyme assay), plasma lipids were evaluated, sonography with measurement of intima-media complex (IMC) thickness of common carotid arteries, carotid artery bulbs and internal carotid arteries, electrocardiography (ECG), echocardiography (EchoCG), Holter ECG monitoring were performed. Results. HsCRP serum level in pts was significantly higher than in control: 2,55 [0,71; 7,04] mg/l (varied from 0,15 to 39,85) vs 0,68 [0,26; 1,97] mg/l (varied from 0,1 to 9,61), p<0,001. Most high hsCRP concentration was found in SLE with APS (p=0,02). HsCRP level in pts with PAPS with history of combined or isolated arterial thrombosis was significantly higher than in pts with SLE and APS having the same localization of thrombosis. HsCRP concentration less than 3 mg/l correlated with duration of postthrombotic period in pts with PAPS. HsCRP level also correlated with triglyceride concentration, body mass index, summated coronary risk and magistral arteries IMC thickness. Conclusion. HsCRP elevation in pts with APS was associated with development of combined and arterial thrombosis as well as with traditional risk factors of atherosclerosis.https://rsp.mediar-press.net/rsp/article/view/1059c-reactive proteinantiphospholipid syndromesystemic lupus erythematosusthrombosisatherosclerosis
spellingShingle N V Seredavkina
T M Reshetnyak
E N Alexandrova
A A Novikov
E S Mach
T V Popkova
C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
Научно-практическая ревматология
c-reactive protein
antiphospholipid syndrome
systemic lupus erythematosus
thrombosis
atherosclerosis
title C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
title_full C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
title_fullStr C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
title_full_unstemmed C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
title_short C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
title_sort c reactive protein in antiphospholipid syndrome relationship with cardiovascular pathology
topic c-reactive protein
antiphospholipid syndrome
systemic lupus erythematosus
thrombosis
atherosclerosis
url https://rsp.mediar-press.net/rsp/article/view/1059
work_keys_str_mv AT nvseredavkina creactiveproteininantiphospholipidsyndromerelationshipwithcardiovascularpathology
AT tmreshetnyak creactiveproteininantiphospholipidsyndromerelationshipwithcardiovascularpathology
AT enalexandrova creactiveproteininantiphospholipidsyndromerelationshipwithcardiovascularpathology
AT aanovikov creactiveproteininantiphospholipidsyndromerelationshipwithcardiovascularpathology
AT esmach creactiveproteininantiphospholipidsyndromerelationshipwithcardiovascularpathology
AT tvpopkova creactiveproteininantiphospholipidsyndromerelationshipwithcardiovascularpathology